Significant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow
|
|
- Elijah Holmes
- 5 years ago
- Views:
Transcription
1 Hematopathology / CD5 Expression on Normal B Cells Significant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow Franklin S. Fuda, DO, Nitin J. Karandikar, MD, PhD, and Weina Chen, MD, PhD Key Words: Hematogones; Mature B cells; CD5; Multiparameter flow cytometry DOI: /AJCPU5E3NXEKLFIY Abstract B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5% of total events). The mean percentage of hematogones was 8.1%. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-hodgkin lymphomas. B-cell maturation from hematogones to mature B cells in bone marrow has been well characterized. 1-6 Hematogones are normal, maturing, B-lineage precursors that exhibit a consistent, reproducible, complex spectrum of sequential antigen expression. This defines hematogones into 3 stages of maturation. Stage 1 hematogones express CD34, high levels of CD10 and CD38, a moderate level of CD22, and absence of CD20. These progress to the intermediate stage 2 as they down-regulate CD34 completely and CD10 partially, while increasing expression of CD22 and CD20. Finally, at stage 3, CD20 expression reaches the intensity of mature B cells and CD10 and CD38 are slightly down-regulated with increasing expression of polytypic surface immunoglobulin (sig) light chains. Subsequently, these cells mature into CD20+/CD10 mature B cells. We had anecdotally observed CD5 expression on a subset of hematogones and mature B cells in bone marrow, particularly in cases with hematogone hyperplasia. The expression pattern of CD5 on B-cell subsets at different stages of maturation and surface light chain expression on these CD5+ B cells had not been systematically studied and became the focus of this study. CD5 is a T cell associated antigen. Its expression on neoplastic B cells is a defining feature of mantle cell lymphoma and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma. Lack of awareness of CD5 expression on normal B cells may lead to erroneous interpretation, particularly in the analysis of minimal residual disease of these CD5+ lymphomas. Therefore, in this study, we systematically evaluated the pattern of CD5 expression on normal B-cell subsets in bone marrow by 4-color flow cytometry and examined whether the differential antigen expression including CD5 would permit the distinction of normal CD5+ B cells from neoplastic CD5+ B cells. Am J Clin Pathol 2009;132: DOI: /AJCPU5E3NXEKLFIY 733
2 Fuda et al / CD5 Expression on Normal B Cells Materials and Methods As CD5 expression on normal B cells was readily appreciable in cases with hematogone hyperplasia, 32 bone marrow cases with hematogone hyperplasia, defined as a percentage of hematogones higher than 3.5% of total events, were prospectively studied. All cases were immunophenotyped using a 4-color FACSCalibur flow cytometry instrument with CellQuest software (Becton Dickinson, San Jose, CA) and analyzed using cluster analysis with Paint-a-Gate Software (Becton Dickinson). Bone marrow processing and antibody staining were performed as previously described. 4 The following monoclonal antibodies (clones) were used in the panels to profile B-cell subsets: CD5 (L17F12), CD10 (W8E7), CD19 (SJ25C1), CD20 (L27), CD22 (S-HCL-1), CD22 (4KB128), CD23 (B6), CD38 (HB7), FMC-7, monoclonal κ (TB28-2), and monoclonal λ (I-155-2). Four-color antibody combinations (fluorescein isothiocyanate/phycoerythrin/peridinin chlorophyll protein/allophycocyanin) were used: CD10/CD19/CD20/CD38, CD10/CD5/CD20/ CD22, FMC-7/CD23/CD5/CD19, and κ/λ/cd5/cd22. Hematogones were divided into 3 stages of maturation, as previously described 4,5 : stage 1 hematogone by the immunophenotype of CD10+ bright /CD45+ dim /CD20 /CD22+; stage 2 by CD10+/CD45+ moderate /CD20+ variable /CD22+; and stage 3 by CD10+/CD45+ moderately bright /CD20+ bright /CD22+ bright. The proportion of cells with CD5 expression was determined for total B-lineage cells, mature B cells, and stage 3 hematogones. Statistical Analysis Statistical analysis was performed using Prism software (version 5.0a, GraphPad Software, La Jolla, CA). The difference of mean hematogones among 3 stages was tested by 1-way analysis of variance (Kruskal-Wallis test) followed by pairwise comparisons (Dunn multiple comparison test). The difference between 2 groups was tested by unpaired t test. A P value of less than.05 was considered statistically significant. Results Patient Characteristics There were 21 males and 11 females aged 9 months to 63 years (median, 35 years). Submitted clinical histories included 27 cases of hematolymphoid neoplasia and 5 cases of cytopenias. Hematolymphoid neoplasia included myelodysplastic syndromes or acute myeloid leukemia in 15 cases, plasma cell myeloma in 6, precursor lymphoblastic leukemia in 4, chronic lymphocytic leukemia in 1, and Fanconi anemia in 1. Flow cytometric findings were unremarkable in 20 (63%) of 32 cases. The remaining 12 cases showed persistence of previously diagnosed neoplasia (11 cases) or newly detected acute myeloid leukemia (1 case). CD5 Expression on Normal B Cells Regardless of the underlying disease and the patient s age, hematogones in each case exhibited a typical, consistent, complex spectrum of sequential antigen expression, as described previously. 4,5 Table 1 summarizes the percentage of total B cells, mature B cells, and each stage of hematogones in bone marrow. Of total events, the mean percentage of total B cells that included mature B cells and hematogones was 10.1%. Likely owing to the selection bias for which only cases with hematogone hyperplasia were included, the mean percentage of hematogones was higher than that of mature B cells (8.13% vs 1.95%; P <.01; unpaired t test). Within the hematogone populations, hematogones were present at all stages of maturation with a predominance of stage 2 hematogones in 31 of 32 cases (mean, 77% vs 8.0% in stage 1 and 15.0% in stage 3 hematogones) Image 1A. In 1 remaining case, moderate hematogone hyperplasia (4.1% of total events) was present with a shift toward immaturity and virtual absence of stage 3 hematogones and mature B cells Image 1B. CD5 was expressed on normal subsets of B cells in a continuum, being most prominent on stage 3 hematogones and mature B cells. Table 2 summarizes the percentage of CD5+ B cells over total B cells, mature B cells, and stage 3 Table 1 The Percentage of Mature B Cells and Hematogones in 32 Bone Marrow Samples Mean ± SD Median Range Total B cells/total events (%) ± Mature B cells/total events (%) 1.95 ± Total hematogones/total events (%) 8.13 ± Stage of hematogones/total hematogones (%) ± ± ± Am J Clin Pathol 2009;132: DOI: /AJCPU5E3NXEKLFIY
3 Hematopathology / Original Article A B C Image 1 Representative flow cytometric plots of hematogones and mature B cells in bone marrow. A, A case with moderate hematogone hyperplasia (6.5% of total events) with all stages of hematogones represented. CD5 expression was evident on stage 3 hematogones and a subset of mature B cells. B, A case with moderate hematogone hyperplasia (4.1% of total events) with a shift toward immaturity (exclusively stage 1 and 2 hematogones detected). Mature B cells were virtually absent. There was no appreciable CD5 expression on stage 1 and 2 hematogones. C, A case with moderate hematogone hyperplasia (4.6% of total events) with all stages of hematogones represented. CD5 was expressed on stage 3 hematogones and a subset of mature B cells. In addition, there was a minute population of clonal B cells (0.22%, in red) with immunophenotype of chronic lymphocytic leukemia (CLL). The differential expression of CD5, CD10, CD20, and surface immunoglobulin light chain (sig) permitted the distinction of CD5+ normal B cells from CD5+ CLL cells. Note that the CD5+ B cells exhibited predominantly polytypic sig expression. APC, allophycocyanin; FITC, fluorescein isothiocyanate; PE, phycoerythrin; PerCP, peridinin chlorophyll protein; green, stage 1 and 2 hematogones; yellow, stage 3 hematogones; blue, mature B cells; red, monotypic B cells. Table 2 CD5 Expression on Mature B Cells and Stage 3 Hematogones in 31 Bone Marrow Samples Mean ± SD Median Range CD5+ B cells/total B cells (%) ± CD5+ mature B cells/total CD5+ B cells (%) ± CD5+ hematogones/total CD5+ B cells (%) ± CD5+ mature B cells/mature B cells (%) ± CD5+ hematogones/stage 3 hematogones (%) ± Am J Clin Pathol 2009;132: DOI: /AJCPU5E3NXEKLFIY 735
4 Fuda et al / CD5 Expression on Normal B Cells hematogones, and their distribution over total CD5+ B cells. The mean percentage of CD5+ B cells over total B cells was 22.8%. CD5+ B cells were approximately equally split between mature B cells (~44%) and stage 3 hematogones (~56%). Within mature B cells, 59.92% were CD5+, whereas 67.07% of the stage 3 hematogones were CD5+. Notably, this subset of CD5+ stage 3 hematogones was also positive for CD10 (a marker used to define all hematogones). Virtually all CD5+ B cells expressed sig, showing a polytypic distribution of light chains. It is interesting that in the 1 case that virtually lacked stage 3 hematogones and mature B cells, CD5 expression on B cells was undetectable (Image 1B). In another case, there was a minute population of CD5+ monotypic B cells (0.22% of total events) with the immunophenotype of CLL. In this case, the differential expression of CD5, CD10, CD20, and sig permitted the distinction of CD5+ normal B cells from CD5+ CLL cells. Compared with normal CD5+ B cells, CLL cells expressed strong CD5, dim CD20, and monotypic sig and lacked CD10 Image 1C. Discussion Hematogones in this study exhibited a typical, consistent, complex spectrum of sequential antigen expression, as described previously. 4,5 The novel finding in this study is CD5 expression on normal subsets of polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. The differential antigen expression, including CD5 and sig light chains, permits the distinction of CD5+ normal B cells from CD5+ lymphoma cells. In this study, we characterized the pattern of CD5 expression in bone marrow cases with hematogone hyperplasia in which CD5 expression was readily appreciable compared with cases with low numbers of hematogones. The majority of patients had a history of hematolymphoid malignancies and were in remission or had minimal residual disease. Therefore, it is conceivable that hematogone hyperplasia was likely associated with postchemotherapy bone marrow regeneration. Another condition associated with hematogone hyperplasia is copper deficiency, which was illustrated in one of our cases that exhibited exuberant hematogone hyperplasia and no evidence of myelodysplastic syndrome. 7 It has been 2 decades since CD5, first described as a T-cell marker, was identified in malignant human B cells. 8 CD5 was later shown to mark a minority of normal B cells in peripheral blood. 9 These CD5+ B cells likely represent so-called transitional B cells or B1 B cells In humans and mice, CD5+ B cells are the major population of B cells in fetal life, and their percentage decreases with age. Indeed, most human IgM+ cord blood B cells express CD5; however, in adults they represent approximately 10% to 25% of B cells in blood and may expand in early lymphoid recovery after hematopoietic stem cell transplantation and autoimmune diseases (such as systemic lupus erythematosus). 11,14-16 These findings may suggest the role of CD5+ B cells in lymphopoiesis and pathogenesis in immune dysregulation. CD5 expression on bone marrow hematogones was described in 1 case report in which there was significant hematogone hyperplasia in a 7-year-old girl with pancytopenia due to Shwachman-Diamond syndrome, shown by 2-color flow cytometric study and morphologic examination. 17 Such CD5 expression likely represents CD5 expression on transitional B cells in the immunologic literature. 11 The pattern of CD5 expression during the different stages of B-cell maturation in bone marrow, however, has not been systematically evaluated. Our studies demonstrate that CD5 is expressed on normal subsets of B cells in a continuum, specifically on stage 3 hematogones and mature B cells. Furthermore, a small subset of normal B cells coexpressed CD5 and CD10 (stage 3 hematogones). These CD5+ B cells may represent a developmental intermediate for mature B-cell generation. Exploration of the mechanism of this highly regulated CD5 expression may shed light on the pathogenesis of CD5+ and dual CD5+/ CD10+ B-cell lymphomas. Furthermore, awareness of the normal pattern of CD5 expression on B cells has clinical implications in the analysis of residual disease in CD5+ B-cell lymphomas such as CLL and mantle cell lymphoma. Our study indicates that differential antigen expression can distinguish normal CD5+ B cells from neoplastic CD5+ B cells. Features associated with CLL include dim CD20 expression, light chain restriction, and lack of CD10. Typically, precursor B lymphoblastic leukemia would not cause a diagnostic challenge in regard to CD5 expression because the vast majority of cases of B lymphoblastic leukemia express CD34 and terminal deoxynucleotidyl transferase and lack CD5, 4,6 an immunophenotype that mimics the normal counterpart of stage 1 hematogones. We show that CD5 is expressed on normal, polytypic B cells, predominantly on stage 3 hematogones and mature B cells. Awareness of this normal expression pattern has clinical implications in the analysis of minimal residual diseases of CD5+ B-cell lymphomas. From the Department of Pathology, University of Texas Southwestern Medical Center, Dallas. Address reprint requests to Dr Chen: Dept of Pathology, UT Southwestern Medical Center at Dallas, Dallas, TX References 1. Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow, II: normal B lymphocyte development. Blood. 1987;70: Am J Clin Pathol 2009;132: DOI: /AJCPU5E3NXEKLFIY
5 Hematopathology / Original Article 2. Ryan DH, Chapple CW, Kossover SA, et al. Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLApositive B cell precursors. Blood. 1987;70: Campana D, Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry. 1999;38: McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98: McKenna RW, Asplund SL, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma. 2004;45: Chen W, Karandikar NJ, McKenna RW, et al. Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience. Am J Clin Pathol. 2007;127: Sutton L, Vusirikala M, Chen W. Hematogone hyperplasia in copper deficiency. Am J Clin Pathol. 2009;132: Boumsell L, Bernard A, Lepage V, et al. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol. 1978;8: Caligaris-Cappio F, Gobbi M, Bofill M, et al. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med. 1982;155: Dono M, Cerruti G, Zupo S. The CD5+ B-cell. Int J Biochem Cell Biol. 2004;36: Marie-Cardine A, Divay F, Dutot I, et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol. 2008;127: Hardy RR. B-1 B cell development. J Immunol. 2006;177: Hardy RR. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol. 2006;18: Dono M, Burgio VL, Tacchetti C, et al. Subepithelial B cells in the human palatine tonsil, I: morphologic, cytochemical and phenotypic characterization. Eur J Immunol. 1996;26: Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today. 1999;20: Youinou P, Renaudineau Y. The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun Rev. 2007;7: Jelic TM, Raj AB, Jin B, et al. Expression of CD5 on hematogones in a 7-year-old girl with Shwachman-Diamond syndrome. Pediatr Dev Pathol. 2001;4: Am J Clin Pathol 2009;132: DOI: /AJCPU5E3NXEKLFIY 737
Sponsored and reviewed by ICCS Quality and Standards Committee Title: Expression of CD5 on Normal Hematolymphoid Cells Written by:
Sponsored and reviewed by ICCS Quality and Standards Committee Title: Expression of CD5 on Normal Hematolymphoid Cells Written by: Weina Chen and Buddy Frank Fuda Date: Jan 25, 2019 INTRODUCTION CD5 was
More informationCME/SAM. Flow Cytometric Immunophenotyping of Cerebrospinal Fluid Specimens
Hematopathology / Flow Cytometric Immunophenotyping of CSF Specimens Flow Cytometric Immunophenotyping of Cerebrospinal Fluid Specimens Fiona E. Craig, MD, 1 N. Paul Ohori, MD, 2 Timothy S. Gorrill, MD,
More informationCME/SAM. Abstract. Hematopathology / CD103 and CD123 in B-Cell Neoplasia
Hematopathology / CD103 and CD123 in B-Cell Neoplasia Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia Usefulness of CD123 and CD103 in the Diagnosis of Mature B-Cell Lymphoproliferative
More informationFlow Cytometric Analysis of Surface Light Chain Expression Patterns in B-Cell Lymphomas Using Monoclonal and Polyclonal Antibodies
Hematopathology / Light Chain Expression in B-NHLs Flow Cytometric Analysis of Surface Light Chain Expression Patterns in B-Cell Lymphomas Using Monoclonal and Polyclonal Antibodies Pedro Horna, MD, Horatiu
More informationMultiparameter flow cytometry can be used to
Minimal residual disease testing in Acute Leukemia Anjum Hassan MD Assistant Professor of Pathology and Immunology, Director FISH laboratory in Anatomic Pathology, Washington University in St Louis, School
More informationLack of Surface Immunoglobulin Light Chain Expression by Flow Cytometric Immunophenotyping Can Help Diagnose Peripheral B-Cell Lymphoma
Hematopathology / SURFACE IMMUNOGLOBULIN LIGHT CHAIN NEGATIVE PERIPHERAL B-CELL LYMPHOMA Lack of Surface Immunoglobulin Light Chain Expression by Flow Cytometric Immunophenotyping Can Help Diagnose Peripheral
More informationHematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic Pitfall
Hematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic Pitfall Tesha Guillory, MD, 1 Shiyong Li, MD, PhD, 1 Daniel J. Bergsagel, MD, 2 Elizabeth
More informationAnaplastic Large Cell Lymphoma A Flow Cytometric Analysis of 29 Cases
Hematopathology / FLOW CYTOMETRY OF ANAPLASTIC LYMPHOMA Anaplastic Large Cell Lymphoma A Flow Cytometric Analysis of 29 Cases Melissa V. Kesler, MD, Geeta S. Paranjape, MD, Sheryl L. Asplund, MD, Robert
More informationFlow Cytometric Analysis of CD5+ B Cells A Frame of Reference for Minimal Residual Disease Analysis in Chronic Lymphocytic Leukemia
Hematopathology / CD5+ -CELL NLYSIS Y FLOW CYTOMETRY Flow Cytometric nalysis of CD5+ Cells Frame of Reference for Minimal Residual Disease nalysis in Chronic Lymphocytic Leukemia Ritu Gupta, MD, 1 Paresh
More informationThe spectrum of flow cytometry of the bone marrow
The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests
More informationMultidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies
TZU CHI MED J March 2009 Vol 21 No 1 available at http://ajws.elsevier.com/tcmj Tzu Chi Medical Journal Original Article Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological
More informationVUmc Basispresentatie
Clinical diagnostic cytometry Gerrit J Schuurhuis Dept of Hematology VU University Medical Center Amsterdam, Netherlands Use of immunophenotyping at diagnosis to trace residual disease after therapy 1.
More informationSuccessful flow cytometric immunophenotyping of body fluid specimens
Successful flow cytometric immunophenotyping of body fluid specimens Fiona E. Craig, MD Division of Hematopathology Mayo Clinic Arizona 2017 MFMER slide-1 Financial disclosure No conflicts 2017 MFMER slide-2
More informationV. Acute leukemia. Flow cytometry in evaluation of hematopoietic neoplasms: A case-based approach
V. Acute leukemia Evaluating a sample for an acute leukemia Acute leukemia is a neoplasm of immature myeloid or lymphoid cells characterized by a block in maturation, usually at the stage of an early progenitor
More informationOriginal Article Acute Leukemias And Aberrant Markers Expression Pak Armed Forces Med J 2018; 68 (3):
Open Access Original Article Acute Leukemias And Aberrant Markers Expression Pak Armed Forces Med J 2018; 68 (3): 450-54 SPECTRUM OF ACUTE LEUKEMIAS AND ABERRANT MARKERS EXPRESSION BASED ON FLOWCYTOMETRY
More informationFLOW CYTOMETRY PRINCIPLES AND PRACTICE. Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018
FLOW CYTOMETRY PRINCIPLES AND PRACTICE Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018 Aims and Objectives Principles of flow cytometry Preparation Steps involved
More informationFLOW CYTOMETRIC ANALYSIS OF NORMAL BONE MARROW
XI International Conference Hematopoiesis Immunology Budapest, June 6-7, 2014 FLO CYTOMETRIC ANALYSIS OF NORMAL BONE MARRO Bruno Brando and Arianna Gatti Hematology Laboratory and Transfusion Center Legnano
More informationImmunopathology of Lymphoma
Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.
More informationCase Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case
Int J Clin Exp Pathol 2014;7(10):7100-7104 www.ijcep.com /ISSN:1936-2625/IJCEP0001717 Case Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case Jenny
More informationDifferential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital
Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic
More informationNormal Blood and Bone Marrow Populations
4 CHAPTER 4 Normal Blood and Bone Marrow Populations It is essential to have a sound understanding of the nature and immunophenotypic characteristics of the normal cell populations encountered in bone
More informationTransient Myeloproliferative Disorder and Acute Myeloid Leukemia in Down Syndrome An Immunophenotypic Analysis
Hematopathology / IMMUNOPHENOTYPE OF TRNSIENT MYELOPROLIFERTIVE DISORDER VS ML IN DOWN SYNDROME Transient Myeloproliferative Disorder and cute Myeloid Leukemia in Down Syndrome n Immunophenotypic nalysis
More informationWBCs Disorders 1. Dr. Nabila Hamdi MD, PhD
WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features
More informationDr Prashant Tembhare
Dr Prashant Tembhare docprt@gmail.com FCM very powerful technology in Identification and characterization of neoplastic plasma cells as it allows - simultaneous assessment of multiple antigens large numbers
More informationCase 3. Ann T. Moriarty,MD
Case 3 Ann T. Moriarty,MD Case 3 59 year old male with asymptomatic cervical lymphadenopathy. These images are from a fine needle biopsy of a left cervical lymph node. Image 1 Papanicolaou Stained smear,100x.
More informationFlow Cytometric Analysis of Cerebral Spinal Fluid Involvement by Leukemia or Lymphoma
Flow Cytometric Analysis of Cerebral Spinal Fluid Involvement by Leukemia or Lymphoma Maryalice Stetler-Stevenson, M.D., Ph.D. Flow Cytometry Unit, Laboratory of Pathology, DCS, NCI, NIH DEPARTMENT OF
More informationDo Your Flow Cytometric LDTs. Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine
Do Your Flow Cytometric LDTs Conform to the ICSH ICCS Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine How should LDTs be validated? Accuracy Specificity Sensitivity
More informationCME/SAM. Olga Pozdnyakova, MD, PhD, 1 Svetlana Kondtratiev, MD, 1,2 Betty Li, MS, 1 Karry Charest, 1 and David M. Dorfman, MD, PhD 1.
Hematopathology / New Mastocytosis Flow Cytometry Approach High-Sensitivity Flow Cytometric Analysis for the Evaluation of Systemic Mastocytosis Including the Identification of a New Flow Cytometric Criterion
More informationAbstract. Hematopathology / HEMATOGONE POPULATIONS
Hematopathology / HEMATOGONE POPULATIONS Benign Hematogone-Rich Lymphoid Proliferations Can Be Distinguished From B-Lineage Acute Lymphoblastic Leukemia by Integration of Morphology, Immunophenotype, Adhesion
More information5000 International Clinical Cytometry Society: Practical Flow Cytometry in Hematopathology A Case-Based Approach
5000 International Clinical Cytometry Society: Practical Flow Cytometry in Hematopathology A Case-Based Approach Joseph A DiGiuseppe, MD, PhD Hartford Hospital Disclosures In the past 12 months, I have
More informationFLOCK Cluster Analysis of Mast Cell Event Clustering by High-Sensitivity Flow Cytometry Predicts Systemic Mastocytosis
FLOCK Cluster Analysis of Mast Cell Event Clustering by High-Sensitivity Flow Cytometry Predicts Systemic Mastocytosis David M. Dorfman, MD, PhD, Charlotte D. LaPlante, Olga Pozdnyakova, MD, PhD, and Betty
More informationCase Workshop of Society for Hematopathology and European Association for Haematopathology
Case 148 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Robert P Hasserjian Department of Pathology Massachusetts General Hospital Boston, MA Clinical history
More informationImmunophenotypic Profile of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
Hematopathology / IMMUNOPHENOTYPE OF LPL/WM Immunophenotypic Profile of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Sergej Konoplev, MD, PhD, L. Jeffrey Medeiros, MD, Carlos E. Bueso-Ramos,
More informationFlow cytometric analysis of B-cell lymphoproliferative disorders
Flow cytometric analysis of B-cell lymphoproliferative disorders David M. Dorfman, M.D., Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard Medical School Boston, MA Objectives Review
More informationBD Flow Cytometry Reagents Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-20 Cell Analyzer
Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-2 Cell Analyzer Proper multicolor panel design takes into account fluorochrome brightness, antigen density, co-expression, and
More informationB-Cell Precursors in Normal Pediatric Bone Marrow
HEMATOPATHOLOGY Original Article B-Cell Precursors in Normal Pediatric Bone Marrow CHARLES W. CALDWELL, M.D., PH.D., EDWARD POJE, M.D., AND MARY A. HELIKSON, M.D. A number of studies have been published
More informationImmunophenotypic Differentiation Between Neoplastic Plasma Cells in Mature B-Cell Lymphoma vs Plasma Cell Myeloma
Hematopathology / PLASMA CELLS IN LYMPHOMA VS MYELOMA Immunophenotypic Differentiation Between Neoplastic Plasma Cells in Mature B-Cell Lymphoma vs Plasma Cell Myeloma Adam C. Seegmiller, MD, PhD, Yin
More informationTest Utilization: Chronic Lymphocytic Leukemia
Test Utilization: Chronic Lymphocytic Leukemia Initial Evaluation Diagnostic Criteria Selection of Tests for Prognosis Response to Therapy Challenges Assessment for persistent disease Paul J. Kurtin, M.D.
More informationMihaela Onciu, MD, Robert B. Lorsbach, MD, PhD, E. Charlene Henry, HTL(ASCP)QIHC, and Frederick G. Behm, MD. Abstract
Hematopathology / TDT-POSITIVE CELLS IN LYMPH NODES Terminal Deoxynucleotidyl Transferase Positive Lymphoid Cells in Reactive Lymph Nodes From Children With Malignant Tumors Incidence, Distribution Pattern,
More informationWelcome. Welcome. Emerging Technologies in Flow Cytometry
Emerging Technologies in Flow Cytometry Dr. William Dittman December 11, 2012 You may download a copy of the handout by clicking on the handout icon, located in the upper right hand corner of your screen
More information7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour
7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic
More informationPrecursor B Lymphoblastic Leukemia With Surface Light Chain Immunoglobulin Restriction A Report of 15 Patients
Hematopathology / PRECURSOR B LYMPHOBLASTIC LEUKEMIA Precursor B Lymphoblastic Leukemia With Surface Light Chain Immunoglobulin Restriction A Report of 15 Patients Rina Kansal, MD, 1 George Deeb, MD, 1
More informationClinical question. Screening tube. Diagnostic panel MRD. Clinical question
OW CYTOMETRY UPDATES IN LYMPHOPROLIFERATIVE DISORDERS CANCER RESEARCH CENTER IBSAL UNIVERSITY & UNIVERSITY HOSPITAL, SALAMANCA (SPAIN) DISCLOSURES The EuroFlow Scientific Consortium Iamco-chairof receives
More informationClassification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
More informationMixed Phenotype Acute Leukemias
Mixed Phenotype Acute Leukemias CHEN GAO; AMY M. SANDS; JIANLAN SUN NORTH AMERICAN JOURNAL OF MEDICINE AND SCIENCE APR 2012 VOL 5 NO.2 INTRODUCTION Most cases of acute leukemia can be classified based
More informationReactive and Neoplastic Lymphocytosis
Reactive and Neoplastic Lymphocytosis Koranda A. Walsh, VMD, BS Assistant Professor, Clinical Pathobiology University of Pennsylvania School of Veterinary Medicine PLEASE NOTE: These notes are meant as
More information2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228
2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07
More informationCLINICAL USE OF CELLULAR SUBPOPULATION ANALYSIS IN BM
CLINICAL USE OF CELLULAR SUBPOPULATION ANALYSIS IN BM CANCER RESEARCH CENTRE, UNIVERSITY AND UNIVERSITY HOSPITAL OF SALAMANCA (SPAIN)( Sao Paulo, 18th of April, 2009 IDENTIFICATION OF HPC (I) 1.- In vivo
More informationPathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e
Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long
More informationThe Role of CD11c Expression in the Diagnosis of Mantle Cell Lymphoma
Hematopathology / CD11c Expression in Mantle Cell Lymphoma The Role of CD11c Expression in the Diagnosis of Mantle Cell Lymphoma Teresa S. Kraus, MD, * Christine N. Sillings, MD, * Debra F. Saxe, PhD,
More informationa resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral
More informationDETERMINATION OF A LYMPHOID PROCESS
Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,
More informationBone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester
Bone marrow morphology in reactive conditions Kaaren K. Reichard, MD Mayo Clinic Rochester reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Outline of Presentation Brief introduction General
More informationPrognostic Value of Plasma Interleukin-6 Levels in Patients with Chronic Lymphocytic Leukemia
1071 Prognostic Value of Plasma Interleukin-6 Levels in Patients with Chronic Lymphocytic Leukemia Raymond Lai, M.D, PhD. 1 Susan O Brien, M.D. 2 Taghi Maushouri, M.S. 1 Anna Rogers, 1 Hagop Kantarjian,
More informationNUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow
Quality ID #67 (NQF 0377): Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow National Quality Strategy Domain: Effective Clinical Care
More informationBeyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for
More informationIntegrated Hematopathology. Morphology and FCI with IHC
Integrated Hematopathology Morphology and FCI with IHC FrontMatter.indd i 9/6/2009 9:30:12 PM FrontMatter.indd ii 9/6/2009 9:30:18 PM Integrated Hematopathology Morphology and FCI with IHC Cherie H Dunphy,
More informationLevels of expression of CD19 and CD20 in chronic B cell leukaemias
364 Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital and Institute of Cancer Research, London SW3, UK E Matutes N Farahat R Morilla D Catovsky Department of Internal Medicine,
More informationDepartment of Veterinary Pathology, University of Milan, Italy
Chronic lymphocytic leukemia/small cell lymphoma in a horse Cian F 1, Tyner G 2, Martini V 3, Comazzi S 3, Archer J 1 1 Department of Veterinary Medicine, University of Cambridge, UK 2 Chiltern Equine
More informationReac%ve and Benign Flow Cytometry findings
Reac%ve and Benign Flow Cytometry findings Lymph nodes and other /ssues Sindhu Cherian, MD University of Washington, Sea
More informationEstablishing a Pure Lymphocyte Gate for Subset Analysis by Flow Cytometry
Cytornetry (Communications in Clinical Cytometry) 26:172-177 (1996) Establishing a Pure Lymphocyte Gate for Subset nalysis by Flow Cytometry Joseph M. Homtinovich, Sara D. Sparks, and Karen P. Mann Clinical
More informationLymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients
Hematopathology / LYMPHOMAS WITH IGM PARAPROTEIN Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Pei Lin, MD, 1 Suyang Hao, MD, 1* Beverly C. Handy, MD, 2 Carlos E. Bueso-Ramos,
More informationCase Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent
Int J Clin Exp Med 2014;7(1):307-311 www.ijcem.com /ISSN:1940-5901/IJCEM1311029 Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Qilin Ao 2, Ying Wang 1, Sanpeng Xu 2,
More informationDiagnostic Usefulness of CD23 and FMC-7 Antigen Expression Patterns in B-Cell Lymphoma Classification
Hematopathology / AND ANTIGEN EXPRESSION IN B-CELL LYMPHOMA CLASSIFICATION Diagnostic Usefulness of and Antigen Expression Patterns in B-Cell Lymphoma Classification Diana P. Garcia, MD, 1* Michele T.
More informationLymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC
Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing
More informationRole of BAFF in B cell Biology and Autoimmunity
Role of BAFF in B cell Biology and Autoimmunity B cell development in health and disease: B-lymphocytes or B cells, and the antibodies they produce, are crucial mediators of humoral immunity, providing
More informationCME. The Role of Multiparameter Flow Cytometry for Detection of Minimal Residual Disease in Acute Myeloid Leukemia
Hematopathology / Minimal Residual Disease in AML The Role of Multiparameter Flow Cytometry for Detection of Minimal Residual Disease in Acute Myeloid Leukemia Adhra Al-Mawali, PhD, 1-3 David Gillis, MBBS,
More informationHEMATOLOGIC MALIGNANCIES BIOLOGY
HEMATOLOGIC MALIGNANCIES BIOLOGY Failure of terminal differentiation Failure of differentiated cells to undergo apoptosis Failure to control growth Neoplastic stem cell FAILURE OF TERMINAL DIFFERENTIATION
More informationCorrespondence should be addressed to Anas Khanfar;
Case Reports in Oncological Medicine, Article ID 949515, 4 pages http://dx.doi.org/10.1155/2014/949515 Case Report Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion
More informationG-CSF-primed autologous and allogeneic bone marrow for transplantation in clinical oncology. Cell content and immunological characteristics
Journal of Physics: Conference Series PAPER OPEN ACCESS G-CSF-primed autologous and allogeneic bone marrow for transplantation in clinical oncology. Cell content and immunological characteristics To cite
More informationCorrigenda. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (revised 4th edition): corrections made in second print run
Corrigenda WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (revised 4th edition): corrections made in second print run In addition to corrections of minor typographical errors, corrections
More informationOriginal article. Key words: Lymphoblastic leukemia, Acute, Childhood, Minimal residual disease, Flow cytometry
Original article DOI: 10.5/kjp.2010.5.11.957 Korean J Pediatr 2010;5(11):957-96 Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction
More informationImmunopathology / IMMUNOPHENOTYPE OF TRANSIENT STRESS LYMPHOCYTOSIS
Immunopathology / IMMUNOPHENOTYPE OF TRANSIENT STRESS LYMPHOCYTOSIS Transient Stress Lymphocytosis An Immunophenotypic Characterization of the Most Common Cause of Newly Identified Adult Lymphocytosis
More informationImmunopathology / IMMUNOPHENOTYPE OF TRANSIENT STRESS LYMPHOCYTOSIS
Immunopathology / IMMUNOPHENOTYPE OF TRANSIENT STRESS LYMPHOCYTOSIS Transient Stress Lymphocytosis An Immunophenotypic Characterization of the Most Common Cause of Newly Identified Adult Lymphocytosis
More informationFlow cytometry for MRD detec1on: Focus on AML. Sindhu Cherian University of Washington, Sea6le, WA, USA
Flow cytometry for MRD detec1on: Focus on AML Sindhu Cherian University of Washington, Sea6le, WA, USA Residual disease in hematopoie1c malignancy Residual disease has tradi:onal been defined by morphology
More informationSupplementary Table 1
Supplementary Table 1 Flow Cytometry Antibodies Antibody Fluorochrome Clone Vendor CD45 PE-cyanine 7 30-F11 D ioscience CD3 Pacific lue 17A2 iolegend (San Diego, CA) CD11b APC M1/70 iolegend (San Diego,
More informationChildren ALL MRD study according to protocol of D. Campana
Children ALL MRD study according to protocol of D. Campana L.Yu. Grivtsova Laboratory of Haematopoiesis Immunology State N.N.Blokhin Russian Cancer Research Center affiliated to the Russian Academy of
More informationPathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16
35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will
More informationImmunophenotyping in the diagnosis of chronic lymphoproliferative disorders
J7 Clin Pathol 1994;47:871-875 871 L eaders~~~~~~~~~~~~~~~~.........;->:>> :*--:-- :- -::-*;:- --::- >:-:;-:: ::;...:::::...::::::::::*::;:;;::;::;::;;:;;:;;::;::;::;;:;;:;:::::::::::::::::: Task Force
More informationPathology of Hematopoietic and Lymphoid tissue
CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis
More informationNormal & Leukaemic haematopoiesis. Dr. Liu Te Chih Dept of Haematology / Oncology National University Health Services Singapore
Normal & Leukaemic haematopoiesis 2010 Dr. Liu Te Chih Dept of Haematology / Oncology National University Health Services Singapore Use of Immunophenotyping today Lineage assignment Differentiation of
More informationBone Marrow Morphology after Therapy and Stem Cell Transplantation. Arash Mohtashamian, MD Naval Medical Center, San Diego
Bone Marrow Morphology after Therapy and Stem Cell Transplantation Arash Mohtashamian, MD Naval Medical Center, San Diego Objectives Bone marrow findings after myeloablative therapy. Effects of recombinant
More informationStandard immunophenotyping of leukemia cells in acute myeloid leukemia (AML)
Clinical immunology Standard immunophenotyping of leukemia cells in acute myeloid leukemia (AML) ` JOLANTA WOZNIAK, JOANNA KOPEÆ-SZLÊZAK Department of Haematological Cytobiology, Institut of Haematology
More information2013 AAIM Pathology Workshop
2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone
More informationDone By : WESSEN ADNAN BUTHAINAH AL-MASAEED
Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Acute Myeloid Leukemia Firstly we ll start with this introduction then enter the title of the lecture, so be ready and let s begin by the name of Allah : We
More informationPhenotypic Heterogeneity of B Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematopathology / PHENOTYPIC HETEROGENEITY IN CLL/SLL Phenotypic Heterogeneity of B Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Bal Kampalath, MD, 1 Maurice P. Barcos,
More informationThe Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D.
The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. OBJECTIVES 1. To understand how ordered Ig gene rearrangements lead to the development
More informationGroup of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and
Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and / or peripheral blood Classified based on cell type
More informationSession 5. Pre-malignant clonal hematopoietic proliferations. Chairs: Frank Kuo and Valentina Nardi
Session 5 Pre-malignant clonal hematopoietic proliferations Chairs: Frank Kuo and Valentina Nardi Pre-malignant clonal hematopoietic proliferations Clonal LYMPHOID proliferations: - Monoclonal gammopathy
More informationPatterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure
Patterns of Lymphoid Neoplasia in Peripheral Blood Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure Dr Baltrucki has received an honorarium for his participation as a faculty presenter in this
More informationCHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009
LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of
More informationImmunophenotypic study of acute leukemia by flow cytometry at BPKMCH.
Nepal Medical Association Building Exhibition Road, Kathmandu Journal of Pathology of Nepal (2013) Vol. 3, 345-350 Association of Clinical Pathologist of Nepal-2010 Journal of PATHOLOGY of Nepal www.acpnepal.com
More informationMyeloproliferative Disorders - D Savage - 9 Jan 2002
Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2
More informationAbsence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood
Hematopathology / CD26 IN MYCOSIS FUNGOIDES Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood Dan Jones, MD, PhD, 1 Nam H. Dang, MD, PhD, 2 Madeleine Duvic,
More informationIndependent Diagnostic Accuracy of Flow Cytometry Obtained From Fine-Needle Aspirates A 10-Year Experience With 451 Cases
Hematopathology / Diagnostic Accuracy of Flow Cytometry Independent Diagnostic Accuracy of Flow Cytometry Obtained From Fine-Needle Aspirates A 10-Year Experience With 451 Cases Erica C. Savage, MD, 1
More informationCase Presentation No. 075
Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology
More informationJournal of the Egyptian Nat. Cancer Inst., Vol. 13, No. 3, September: , 2001
Journal of the Egyptian Nat. Cancer Inst., Vol. 13, No. 3, September: 191-201, 2001 Expression of the C-KIT Molecule in Acute Myeloid Leukemias: Implications of the Immunophenotypes CD117 and CD15 in the
More informationRon Lee, MD Hematopathologist, Esoterix Pathology Practice Group, PC Brentwood, TN Office Cellular
Ron Lee, MD Hematopathologist, Esoterix Pathology Practice Group, PC Brentwood, TN Office 615-377-7145 Cellular 615-715-9599 Email ron.lee@labcorp.com Disclosure In the past 12 months, I have not had a
More informationBurkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8
Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology
More information